Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...
A panelist discusses how clinicians should systematically adopt evidence-based hidradenitis suppurativa (HS) guidelines while maintaining flexibility to tailor treatments to individual patient needs, ...
Hidradenitis suppurativa treatment experiences vary widely among patients; a new study highlights the need for personalised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback